Kay J - Search Results

1

The safety of emerging biosimilar drugs for the treatment of rheumatoid arthritis.

Braun J, Kay J. Braun J, et al. Among authors: kay j. Expert Opin Drug Saf. 2017 Mar;16(3):289-302. doi: 10.1080/14740338.2017.1273899. Epub 2017 Jan 10. Expert Opin Drug Saf. 2017. PMID: 28068848 Review.

2

The role of interleukin-1 in the pathogenesis of rheumatoid arthritis.

Kay J, Calabrese L. Kay J, et al. Rheumatology (Oxford). 2004 Jun;43 Suppl 3:iii2-iii9. doi: 10.1093/rheumatology/keh201. Rheumatology (Oxford). 2004. PMID: 15150426 Review.

3

Effects of Teriparatide on Joint Erosions in Rheumatoid Arthritis: A Randomized Controlled Trial.

Solomon DH, Kay J, Duryea J, Lu B, Bolster MB, Yood RA, Han R, Ball S, Coleman C, Lo E, Wohlfahrt A, Sury M, Yin M, Yu Z, Zak A, Gravallese EM. Solomon DH, et al. Among authors: kay j. Arthritis Rheumatol. 2017 Sep;69(9):1741-1750. doi: 10.1002/art.40156. Epub 2017 Jul 14. Arthritis Rheumatol. 2017. PMID: 28544807 Clinical Trial.

4

Anti-cyclic citrullinated peptide antibodies, other common autoantibodies, and smoking as risk factors for lymphoma in patients with rheumatoid arthritis.

Baecklund E, Backlin C, Rönnelid J, Toes R, Huizinga T, Åhlin E, Askling J, Hochberg FH, Klareskog L, Kay J, Smedby KE. Baecklund E, et al. Among authors: kay j. Scand J Rheumatol. 2018 Jul;47(4):270-275. doi: 10.1080/03009742.2017.1376108. Epub 2018 Jan 16. Scand J Rheumatol. 2018. PMID: 29336646

5

Impact of immunogenicity on efficacy and tolerability of tumour necrosis factor inhibitors: pooled analysis of biosimilar studies in rheumatoid arthritis.

Emery P, Suh CH, Weinblatt ME, Smolen JS, Keystone EC, Genovese M, Vencovsky J, Kay J, Hong E, Baek Y, Ghil J. Emery P, et al. Among authors: kay j. Scand J Rheumatol. 2020 Sep;49(5):361-370. doi: 10.1080/03009742.2020.1732458. Epub 2020 May 29. Scand J Rheumatol. 2020. PMID: 32468892

6

Identification and characterization of opsonic fibronectin in synovial fluids of patients with active rheumatoid arthritis.

Kay J, Austen KF, Czop JK. Kay J, et al. Arthritis Rheum. 1991 Jun;34(6):687-96. doi: 10.1002/art.1780340609. Arthritis Rheum. 1991. PMID: 1711322

7

The unmet need in rheumatology: Reports from the targeted therapies meeting 2017.

Winthrop KL, Strand V, van der Heijde D, Mease P, Crow M, Weinblatt M, Bathon J, Burmester GR, Dougados M, Kay J, Mariette X, Van Vollenhoven R, Sieper J, Melchers F, Breedfeld FC, Kalden J, Smolen JS, Furst DE. Winthrop KL, et al. Among authors: kay j. Clin Immunol. 2018 Jan;186:87-93. doi: 10.1016/j.clim.2017.08.009. Epub 2017 Aug 12. Clin Immunol. 2018. PMID: 28811201

8

Utility of high-resolution ultrasound for the diagnosis of dialysis-related amyloidosis.

Kay J, Benson CB, Lester S, Corson JM, Pinkus GS, Lazarus JM, Owen WF Jr. Kay J, et al. Arthritis Rheum. 1992 Aug;35(8):926-32. doi: 10.1002/art.1780350812. Arthritis Rheum. 1992. PMID: 1642657

9

Enhancement of human monocyte beta-glucan receptors by glucocorticoids.

Kay J, Czop JK. Kay J, et al. Immunology. 1994 Jan;81(1):96-102. Immunology. 1994. PMID: 8132226 Free PMC article.

10

Best practices to quantify the impact of reproductive toxicants on development, function, and diseases of the rodent mammary gland.

Matouskova K, Szabo GK, Daum J, Fenton SE, Christiansen S, Soto AM, Kay JE, Cardona B, Vandenberg LN. Matouskova K, et al. Among authors: kay je. Reprod Toxicol. 2022 Jun 25:S0890-6238(22)00096-X. doi: 10.1016/j.reprotox.2022.06.011. Online ahead of print. Reprod Toxicol. 2022. PMID: 35764275

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results